Press release

Business Wire1 week ago

Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease

SUGAR LAND, Texas–(BUSINESS WIRE)–#biopharma–Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase…
Read More »
Press Release

Cision PR Newswire1 week ago
0

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ — MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat (KPSIAJ) announced the signing of…
Read More »
Cision PR Newswire1 week ago
0

Warner Bros. Discovery Confirms Receipt of Amended, Unsolicited Tender Offer from Paramount Skydance

NEW YORK, Dec. 22, 2025 /PRNewswire/ — Warner Bros. Discovery, Inc. (“Warner Bros. Discovery” or “WBD”) (NASDAQ: WBD) today confirmed…
Read More »
Press Release

Cision PR Newswire1 week ago
0

FINALS, SEMI-FINALS AND NON-STOP ACTION AS GOTF 2025 REACHES CLIMAX

On the penultimate day of competition, teams across various disciplines battled for a place in the finals, while Phygital Drone…
Read More »
Business Wire1 week ago

Northwell to Launch Long Island’s First Pancreas Transplant Program

Northwell Transplant Institute is one of 59 adult transplant centers in the U.S. to offer heart, kidney, liver, lung and…
Read More »
Business Wire1 week ago

Securities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Charming Medical Limited (“Charming” or the “Company”)…
Read More »
Business Wire1 week ago

SABA Announces $0.10 Special Dividend

NEW YORK–(BUSINESS WIRE)–Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed…
Read More »
Business Wire1 week ago

Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan

Ustekinumab BS Subcutaneous Injection 45mg Syringes ‘NIPRO’ has been granted marketing approval in Japan First marketing approval under the partnership…
Read More »
Business Wire1 week ago

FFIV ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of F5, Inc. Investors

NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf…
Read More »
Business Wire1 week ago

Harvest ETFs Announces Revised Estimated Annual 2025 Reinvested Harvest High Income Shares ETFs Distributions

OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) announces the estimated annual reinvested distributions for Harvest High Income Shares ETFs TM…
Read More »

Previous page Next page